These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals. Wen J; Batabyal D; Knutson N; Lord H; Wikström M J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605 [TBL] [Abstract][Full Text] [Related]
12. Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation. Brinson RG; Elliott KW; Arbogast LW; Sheen DA; Giddens JP; Marino JP; Delaglio F J Biomol NMR; 2020 Nov; 74(10-11):643-656. PubMed ID: 32700053 [TBL] [Abstract][Full Text] [Related]
13. Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding. Majumder S; Saati A; Philip S; Liu LL; Stephens E; Rouse JC; Alphonse Ignatius A Pharm Res; 2019 Jul; 36(9):130. PubMed ID: 31264003 [TBL] [Abstract][Full Text] [Related]
14. On the Analytical Superiority of 1D NMR for Fingerprinting the Higher Order Structure of Protein Therapeutics Compared to Multidimensional NMR Methods. Poppe L; Jordan JB; Rogers G; Schnier PD Anal Chem; 2015 Jun; 87(11):5539-45. PubMed ID: 25929316 [TBL] [Abstract][Full Text] [Related]
15. Best Practices in Utilization of 2D-NMR Spectral Data as the Input for Chemometric Analysis in Biopharmaceutical Applications. Brinson RG; Arbogast LW; Marino JP; Delaglio F J Chem Inf Model; 2020 Apr; 60(4):2339-2355. PubMed ID: 32249579 [TBL] [Abstract][Full Text] [Related]
16. Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics. Perodeau J; Arbogast LW; Nieuwkoop AJ Mol Pharm; 2023 Mar; 20(3):1480-1489. PubMed ID: 36702622 [TBL] [Abstract][Full Text] [Related]
18. Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb. Solomon TL; Delaglio F; Giddens JP; Marino JP; Yu YB; Taraban MB; Brinson RG MAbs; 2023; 15(1):2160227. PubMed ID: 36683157 [TBL] [Abstract][Full Text] [Related]
19. Application of Natural Isotopic Abundance ¹H-¹³C- and ¹H-¹⁵N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics. Arbogast LW; Brinson RG; Marino JP Methods Enzymol; 2016; 566():3-34. PubMed ID: 26791974 [TBL] [Abstract][Full Text] [Related]
20. NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products. Wang D; Zhuo Y; Karfunkle M; Patil SM; Smith CJ; Keire DA; Chen K Molecules; 2021 Jul; 26(14):. PubMed ID: 34299526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]